Atyr Pharma 2017 Cowen Healthcare Conference Presentation

Atyr Pharma presented its physiocrine platform and pipeline at the 2017 Cowen Healthcare Conference, focusing on novel therapeutics for dysregulated immune systems and rare diseases. The company highlighted two lead programs—Resolaris for rare myopathies and Stalaris for rare lung diseases—supported by >80 issued patents and a strong management team with experience in 18 approved drugs.